Unique regulation of the matrix metalloproteinase, gelatinase B
- PMID: 7890493
Unique regulation of the matrix metalloproteinase, gelatinase B
Abstract
Purpose: The matrix metalloproteinase (MMP), gelatinase B, is expressed by both corneal cell types found at the epithelial-stromal tissue interface, the site of basement membrane repair in the healing cornea. This study investigates the relative regulation of gelatinase B compared to other MMPs in response to agents related to those found in the corneal repair environment or in corneal ulcers.
Methods: A culture model of corneal cells isolated from rabbit was used.
Results: Gelatinase B is the major MMP expressed by corneal epithelial cells, whereas stromal fibroblasts produce gelatinase B along with three other MMPs: collagenase, stromelysin, and gelatinase A. Phorbol-12-myristate 13-acetate (PMA) stimulates gelatinase B mRNA and protein synthesis by corneal cells, which is similar to its effect on the other MMPs. Stimulation occurs, at least partially, at the transcriptional level. PMA-stimulated MMP expression follows biphasic kinetics, with the major effect on collagenase, stromelysin, and gelatinase A occurring during the late component. In contrast, the major gelatinase B response occurs during the early component. Transforming growth factor-beta (TGF-beta) has no effect on constitutive expression of gelatinase B by fibroblasts; however, expression stimulated by PMA is enhanced. In contrast, constitutive expression of collagenase and stromelysin is inhibited by TGF-beta. However, in the presence of PMA, the initial inhibitory effect of TGF-beta is reversed after treatment.
Conclusion: Gelatinase B expression is regulated differently from other corneal MMPs. This provides a mechanism for control of basement membrane repair independent of repair processes in the stroma.
Similar articles
-
Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium.Invest Ophthalmol Vis Sci. 1995 Feb;36(2):345-54. Invest Ophthalmol Vis Sci. 1995. PMID: 7843905
-
Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.Invest Ophthalmol Vis Sci. 1991 Aug;32(9):2441-54. Invest Ophthalmol Vis Sci. 1991. PMID: 1651296
-
A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2.Invest Ophthalmol Vis Sci. 1995 Jan;36(1):151-62. Invest Ophthalmol Vis Sci. 1995. PMID: 7822142
-
Matrix metalloproteinases in periodontal tissue remodelling.Matrix Suppl. 1992;1:352-62. Matrix Suppl. 1992. PMID: 1480060 Review.
-
Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity.Ann N Y Acad Sci. 1999 Jun 30;878:12-24. doi: 10.1111/j.1749-6632.1999.tb07671.x. Ann N Y Acad Sci. 1999. PMID: 10415717 Review.
Cited by
-
Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype.Nat Med. 2001 Mar;7(3):304-9. doi: 10.1038/85446. Nat Med. 2001. PMID: 11231628 Free PMC article.
-
Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.J Cell Physiol. 2009 Nov;221(2):402-11. doi: 10.1002/jcp.21869. J Cell Physiol. 2009. PMID: 19626678 Free PMC article.
-
Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma.Front Vet Sci. 2021 Mar 18;8:641265. doi: 10.3389/fvets.2021.641265. eCollection 2021. Front Vet Sci. 2021. PMID: 33816586 Free PMC article.
-
Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.Mol Vis. 2020 Jul 29;26:540-562. eCollection 2020. Mol Vis. 2020. PMID: 32818017 Free PMC article.
-
Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea.Br J Pharmacol. 1999 May;127(2):489-97. doi: 10.1038/sj.bjp.0702550. Br J Pharmacol. 1999. PMID: 10385250 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources